Neurontin was first released in the mid 90’s by Parke-Davis and is now sold by Pfizer. The FDA approved Neurontin for treatment of epileptic seizures. However, it is believed that almost 80 percent of prescriptions written for Neurontin are for treatment of illnesses other than epilepsy and seizures, so called off-labeling. This widespread practice, may put thousands of people at risk. Before Pfizer stepped in, allegations were made against Parke-Davis, regarding falsification of medical information and studies to promote Neurontin’s off-label use. Worse yet, the U.S. Attorney’s office in Boston uncovered evidence showing that Parke-Davis gave illegal kickbacks to doctors who prescribed the drug. The unethical practices and off-labeling has contributed to Neurontin becoming the most widely prescribed anticonvulsant in the United States.
Neurontin is used for the following disorders, without FDA approval:
- Bipolar Disorder
- Pain Syndromes, Peripheral Neuropathy, and Diabetic Neuropathy
- Amyotrophic Lateral Sclerosis (ALS), Lou Gehrig’s disease
- Reflex Sympathetic Dystrophy (RSD)
- Attention Deficit Disorder (ADD)
- Restless Leg Syndrome (RLS)
- Trigeminal Neuralgia
- Essential Tremor Periodic Limb Movement
- Drug and Alcohol Withdrawal Seizures
Even though Neurontin and other anticonvulsants have been linked to increased suicidal behavior, the drug companies knew the risk and promoted Neurontin for disorders it was not proven to help.
If you or loved one have been injured as a result of taking the above drug, you may have a valid claim. Call Cellino & Barnes now at (800) 888-8888 or contact us.